[
    [
        {
            "time": "2021-10-21",
            "original_text": "康泰生物三季报净利润增长139%，北上资金三季度增持817万股",
            "features": {
                "keywords": [
                    "康泰生物",
                    "三季报",
                    "净利润",
                    "增长139%",
                    "北上资金",
                    "增持"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物三季报净利润增长139%，北上资金三季度增持817万股",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-10-21",
            "original_text": "康泰生物第三季度净利大增三倍 新品种逐渐步入收获期",
            "features": {
                "keywords": [
                    "康泰生物",
                    "第三季度",
                    "净利",
                    "大增三倍",
                    "新品种",
                    "收获期"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "康泰生物第三季度净利大增三倍 新品种逐渐步入收获期",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-10-21",
            "original_text": "康泰生物：前三季度净利润10.36亿元 同比增长139.13%",
            "features": {
                "keywords": [
                    "康泰生物",
                    "前三季",
                    "净利润",
                    "10.36亿元",
                    "同比增长139.13%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物：前三季度净利润10.36亿元 同比增长139.13%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-10-21",
            "original_text": "康泰生物公布三季报 前三季净利增加139.13%",
            "features": {
                "keywords": [
                    "康泰生物",
                    "三季报",
                    "前三季",
                    "净利",
                    "增加139.13%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物公布三季报 前三季净利增加139.13%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-10-21",
            "original_text": "康泰生物第三季度归母净利润7亿元，同比增长303.21%",
            "features": {
                "keywords": [
                    "康泰生物",
                    "第三季度",
                    "归母净利润",
                    "7亿元",
                    "同比增长303.21%"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物第三季度归母净利润7亿元，同比增长303.21%",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-10-21",
            "original_text": "图解康泰生物三季报：第三季度单季净利润同比增303.21%",
            "features": {
                "keywords": [
                    "康泰生物",
                    "三季报",
                    "第三季度",
                    "单季",
                    "净利润",
                    "同比增303.21%"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "图解康泰生物三季报：第三季度单季净利润同比增303.21%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-10-21",
            "original_text": "康泰生物最新公告：第三季度净利升303.21%至7.00亿元",
            "features": {
                "keywords": [
                    "康泰生物",
                    "最新公告",
                    "第三季度",
                    "净利",
                    "升303.21%",
                    "7.00亿元"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物最新公告：第三季度净利升303.21%至7.00亿元",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        }
    ]
]